Christopher Bradley
Physician Assistant · Mooresville, NCNPI 1790144558
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,475 of the $63,086 with a category attached, or 78.4%. AbbVie accounts for 69.5% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2023 at $23,630 and has fallen 54.8% since, to $10,678 in 2025. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 544 payments — averaging $115.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$44K
- Axsome Therapeutics, Inc.$13K
- Otsuka America Pharmaceutical, Inc.$858
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$757
- Teva Pharmaceuticals USA, Inc.$457
- Supernus Pharmaceuticals, Inc.$389
- plus $4K from 26 others
What the payments were for
- Consulting fees$2,2504%
- Speaking & faculty fees$49,47578%
- Travel & lodging$2,5654%
- Food & beverage$8,74714%
- Education$490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 148 | $43,861 |
| Axsome Therapeutics, Inc. | 72 | $13,183 |
| Otsuka America Pharmaceutical, Inc. | 48 | $858 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 39 | $757 |
| Teva Pharmaceuticals USA, Inc. | 19 | $457 |
| Supernus Pharmaceuticals, Inc. | 18 | $389 |
| Alkermes, Inc. | 25 | $386 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $334 |
| Novo Nordisk | 9 | $329 |
| Lundbeck LLC | 14 | $263 |
| Neos Therapeutics, LP | 24 | $262 |
| Sunovion Pharmaceuticals Inc. | 14 | $239 |
| Tris Pharma Inc | 13 | $230 |
| Vanda Pharmaceuticals Inc. | 14 | $208 |
| Neurocrine Biosciences, Inc. | 10 | $204 |
| Jazz Pharmaceuticals Inc. | 4 | $181 |
| Noven Therapeutics, LLC | 8 | $141 |
| Johnson & Johnson | 6 | $119 |
| Corium, LLC | 5 | $108 |
| Harmony Biosciences LLC | 4 | $94 |
| Idorsia Pharmaceuticals US Inc | 5 | $85 |
| Eisai Inc. | 5 | $80 |
| Lilly USA, LLC | 4 | $77 |
| Indivior Inc. | 2 | $39 |
| Merck | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Adlon Therapeutics L.p. | 2 | $34 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| AstraZeneca | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$63,086 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 26 | $27,100 |
| VraylarCariprazine Hcl | 11 | $14,920 |
| TrintellixVortioxetine Hydrobromide | 13 | $6,289 |
| Adderall XrDextroamphetamine/Amphetamine | 13 | $4,879 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $1,109 |
| Fluoxetine Hcl | 21 | $218 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $175 |
| Quetiapine Fumarate | 12 | $142 |
| Aripiprazole | 12 | $96 |
| Bupropion XlBupropion Hcl | 16 | $91 |
| Trazodone Hcl | 14 | $50 |
| Clonazepam | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $13,183 | $27,10026 claims |
| AbbVieVraylar | $43,861 | $14,92011 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $334 | $6,28913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Mooresville
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.